FDA Inspection 1288280 — Swiss Pharmaceutical Company Ltd

Swiss Pharmaceutical Company Ltd — FEI 3011773475

The FDA completed an inspection of Swiss Pharmaceutical Company Ltd on September 12, 2025 in Tai Nan Shi. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 12, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tai Nan Shi (Taiwan)